Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Nagase T et al. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes. 1997 Am. J. Respir. Crit. Care Med. pmid:9372685
Snyder F CDP-choline:alkylacetylglycerol cholinephosphotransferase catalyzes the final step in the de novo synthesis of platelet-activating factor. 1997 Biochim. Biophys. Acta pmid:9370322
Saeed SA et al. Anti-thrombotic and anti-inflammatory activities of protopine. 1997 Pharmacol. Res. pmid:9368908
Manna SK et al. Hamycin inhibits IL-8-induced biologic response by modulating its receptor in human polymorphonuclear neutrophils. 1997 J. Immunol. pmid:9366432
Kishimoto S et al. Comparison of platelet-activating factor receptor mRNA levels in peripheral blood eosinophils from normal subjects and atopic asthmatic patients. 1997 Int. Arch. Allergy Immunol. pmid:9363928
Hershkowitz M and Adunsky A Binding of platelet-activating factor to platelets of Alzheimer's disease and multiinfarct dementia patients. 1996 Nov-Dec Neurobiol. Aging pmid:9363797
Radonjic-Lazovic G and Roudebush WE The effect of short- vs. long-term platelet-activating factor exposure on mouse preimplantation embryo development. 1995 Early Pregnancy pmid:9363251
May JA et al. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man. 1997 Thromb. Res. pmid:9361371
Wang H et al. Platelet-activating factor (PAF) up-regulates plasma and tissue PAF-acetylhydrolase activity in the rat: effect of cycloheximide. 1997 Pediatr. Res. pmid:9357930
Silomon M et al. Role of platelet-activating factor in hepatocellular Ca2+ alterations during hemorrhagic shock. 1997 J. Surg. Res. pmid:9356229
Liu B et al. Prolonged activation of phospholipase D in Chinese hamster ovary cells expressing platelet-activating-factor receptor lacking cytoplasmic C-terminal tail. 1997 Biochem. J. pmid:9355758
Nagaoka H et al. 2-(3-Pyridyl)thiazolidine-4-carboxamides. 1. Novel orally active antagonists of platelet-activating factor (PAF). 1997 Chem. Pharm. Bull. pmid:9353894
Howarth PH Mediators of nasal blockage in allergic rhinitis. 1997 Allergy pmid:9353555
Denham W et al. Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis. 1997 Gastroenterology pmid:9352880
Bzeizi KI et al. Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. 1997 Liver Transpl Surg pmid:9346727
Aspey BS et al. Effects of combined glutamate and platelet-activating factor inhibition on the outcome of focal cerebral ischaemia - an initial screening study. 1997 Metab Brain Dis pmid:9346472
Million M et al. Effects of neuropeptide FF on intestinal motility and temperature changes induced by endotoxin and platelet-activating factor. 1997 Eur. J. Pharmacol. pmid:9346330
Bastos da Silva MB et al. The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves. 1997 Vet. Res. Commun. pmid:9345719
Iwamoto S et al. The release mechanism of platelet-activating factor during shear-stress induced platelet aggregation. 1997 Biochem. Biophys. Res. Commun. pmid:9345277
Rezaul K et al. Platelet-activating factor stimulates calcium-dependent activation of protein-tyrosine kinase Syk in a human B cell line. 1997 Biochem. Biophys. Res. Commun. pmid:9345263
Bastos da Silva M et al. Morphological alterations of blood platelets induced by platelet activating factor (PAF) and partial inhibition by ketoprofen in calves. 1997 Sep-Oct Vet. Res. pmid:9342825
Francescangeli E et al. Activities of enzymes involved in the metabolism of platelet-activating factor in neural cell cultures during proliferation and differentiation. 1997 Neurochem. Res. pmid:9342735
Hirashima Y et al. Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. 1997 Neurochem. Res. pmid:9342729
Ohashi Y et al. Platelet activating factor compromises airway epithelial defense functions. 1997 J. Allergy Clin. Immunol. pmid:9338547
Greiff L et al. Effects of topical platelet activating factor on the guinea-pig tracheobronchial mucosa in vivo. 1997 Acta Physiol. Scand. pmid:9338520
Getting SJ et al. Molecular determinants of monosodium urate crystal-induced murine peritonitis: a role for endogenous mast cells and a distinct requirement for endothelial-derived selectins. 1997 J. Pharmacol. Exp. Ther. pmid:9336316
Knight D et al. Adenosine A3 receptor stimulation inhibits migration of human eosinophils. 1997 J. Leukoc. Biol. pmid:9335316
Ohkuni H et al. Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65. 1997 Adv. Exp. Med. Biol. pmid:9331745
Weber C and Springer TA Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. 1997 J. Clin. Invest. pmid:9329974
DeLano FA et al. Attenuation of oxygen free radical formation and tissue injury during experimental inflammation by P-selectin blockade. 1997 Microcirculation pmid:9329011
Murray J et al. Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. 1997 Blood pmid:9326245
Si Y et al. The change in plasma PAF activity before and after delivery. 1997 Adv. Exp. Med. Biol. pmid:9322006
Aoki Y et al. A simple, rapid and specific radioreceptor assay for platelet-activating factor. 1997 Adv. Exp. Med. Biol. pmid:9321990
Muguruma K et al. The central role of PAF in necrotizing enterocolitis development. 1997 Adv. Exp. Med. Biol. pmid:9321979
Erickson KL et al. Alteration of platelet activating factor-induced macrophage tumoricidal response, IA expression, and signal transduction by N-3 fatty acids. 1997 Adv. Exp. Med. Biol. pmid:9321978
Mori M et al. Localization of platelet-activating factor receptor in the rat brain. 1997 Adv. Exp. Med. Biol. pmid:9321976
Shimizu T and Mutoh H Structure and regulation of platelet activating factor receptor gene. 1997 Adv. Exp. Med. Biol. pmid:9321953
Nakao A et al. cAMP mediates homologous downregulation of PAF receptor mRNA expression in mesangial cells. 1997 Am. J. Physiol. pmid:9321918
Wan S et al. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. 1997 Chest pmid:9315800
Cepinskas G et al. Transendothelial neutrophil migration. Role of neutrophil-derived proteases and relationship to transendothelial protein movement. 1997 Circ. Res. pmid:9314844
Teixeira MM et al. Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. 1997 J. Clin. Invest. pmid:9312163
Cortijo J et al. Pharmacological activity of PF-904 in guinea pig in vivo, and on human bronchus and neutrophils in vitro. 1997 Eur. J. Pharmacol. pmid:9311663
Tailor A et al. Dexamethasone inhibits leukocyte emigration in rat mesenteric post-capillary venules: an intravital microscopy study. 1997 J. Leukoc. Biol. pmid:9307068
Oh-ishi S [Analysis of chemical mediators involved in acute inflammatory reaction with the rat pleurisy model]. 1997 Nippon Yakurigaku Zasshi pmid:9306414
Ablett JM et al. Influence of antigen challenge on platelet responsiveness in horses with chronic obstructive pulmonary disease. 1997 Equine Vet. J. pmid:9306066
Balsa D et al. Effect of endotoxin and platelet-activating factor on rat vascular permeability: role of vasoactive mediators. 1997 J Lipid Mediat Cell Signal pmid:9302653
Bialasiewicz P et al. Altered intracellular calcium signalling after PAF stimulations in polymorphonuclear leukocytes from asthmatic patients. 1997 J Lipid Mediat Cell Signal pmid:9302652
Herbert JM et al. Pharmacological evidence for the putative existence of two different subtypes of PAF receptors on platelets and leukocytes; studies with yangambin. 1997 J Lipid Mediat Cell Signal pmid:9302650
Kimura M et al. Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9301630
Marr KA et al. Effect of antigen challenge on the activation of peripheral blood neutrophils from horses with chronic obstructive pulmonary disease. 1997 May-Jun Res. Vet. Sci. pmid:9300544